Dr.Reddy's Laboratories Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dr.Reddy's Laboratories Ltd with three other
companies in this sector in India:
Aurobindo Pharma Ltd
sales of 164.63 billion Indian Rupees [US$2.39 billion]
(151.56 billion Indian Rupees [US$2.20 billion]
of which 100%
was Pharmaceuticals), and
(158.04 billion Indian Rupees [US$2.29 billion]
of which 100%
Dr.Reddy's Laboratories Ltd reported sales of 142.03 billion Indian Rupees (US$2.06 billion)
March of 2018.
a very small
increase of 0.9%
versus 2017, when the company's sales were 140.81 billion Indian Rupees.
Despite this increase, sales are still
below the level achieved in 2016, when Dr.Reddy's Laboratories Ltd
reported sales of 154.71 billion Indian Rupees.
Sales of Formulations/propreietary Products saw an increase
that was more than double the company's growth rate: sales were up
79.6% in 2018, from
2.36 billion Indian Rupees to 4.25 billion Indian Rupees.
Dr.Reddy's Laboratories Ltd also saw significant increases in sales in
Active Pharmaceutical Ingredients and In (up 3.4% to 21.99 billion Indian Rupees)
Not all segments of Dr.Reddy's Laboratories Ltd experienced an increase in sales in 2018:
sales of Global Generics fell 1.2% to 114.01 billion Indian Rupees.